Lingyan Fei
Impact in
Papers in
-
- Metabolism, Diabetes, and Cancer 1
-
- Acute Kidney Injury Research 2
- Co-authors
- Zhihua Zheng (6 shared papers)Andreas Patzak (5 shared papers)Li Yu (4 shared papers)Xubin Liu (4 shared papers)Shangwu Chen (4 shared papers)Pontus B. Persson (4 shared papers)Shan Jiang (3 shared papers)En Yin Lai (3 shared papers)
- Journals
- Scientific Reports (1 paper)Frontiers in Immunology (1 paper)Hypertension (1 paper)Advanced Science (1 paper)Diagnostic Cytopathology (1 paper)
- Partner nations
- ChinaGermanyUnited States
In The Last Decade
Lingyan Fei
13 papers receiving 329 citations
Peers
Comparison fields: 5 of 66
- Biological Psychiatry 13
- Nephrology 34
- Physiology 98
- Cancer Research 45
- Obstetrics and Gynecology 22
Countries citing papers authored by Lingyan Fei
This map shows the geographic impact of Lingyan Fei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingyan Fei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingyan Fei more than expected).
Fields of papers citing papers by Lingyan Fei
This network shows the impact of papers produced by Lingyan Fei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingyan Fei. The network helps show where Lingyan Fei may publish in the future.
Co-authors
The 25 scholars most cited alongside Lingyan Fei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 155 | |
| 2 | 2022 | 50 | |
| 3 | 2019 | 47 | |
| 4 | 2020 | 17 | |
| 5 | 2023 | 16 | |
| 6 | 2021 | 15 | |
| 7 | 2024 | 9 | |
| 8 | 2024 | 7 | |
| 9 | 2020 | 5 | |
| 10 | 2022 | 4 | |
| 11 | 2017 | 4 | |
| 12 | 2022 | 2 | |
| 13 | 2023 | 1 | |
| 14 | 2025 | 0 | |
| 15 | 2025 | 0 |
About Lingyan Fei
Lingyan Fei is a scholar working on Molecular Biology, Nephrology, Surgery, Epidemiology and Physiology, having authored 15 papers that have together received 332 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (3 papers), Cervical Cancer and HPV Research (3 papers), Acute Kidney Injury Research (2 papers), Erythrocyte Function and Pathophysiology (2 papers), Immune Response and Inflammation (2 papers), Metabolism, Diabetes, and Cancer (1 paper), Systemic Sclerosis and Related Diseases (1 paper) and Hemodynamic Monitoring and Therapy (1 paper). The work is most often cited by research in Biological Psychiatry (13 citations), Nephrology (34 citations), Physiology (98 citations), Cancer Research (45 citations) and Obstetrics and Gynecology (22 citations). Lingyan Fei has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Zhihua Zheng, Andreas Patzak, Li Yu, Xubin Liu, Shangwu Chen, Pontus B. Persson, Shan Jiang, En Yin Lai, Liantang Wang and Xiaohua Wang. Their work appears in journals such as Scientific Reports, Frontiers in Immunology, Hypertension, Advanced Science and Diagnostic Cytopathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.